Titre :
  • Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial
Auteur : Burris, Howard H.A. ; Lebrun, Fabienne ; Piccart-Gebhart, Martine ; Rugo, Hope ; Beck, Joseph Thaddeus ; Neven, Patrick ; Baselga, José ; Petrakova, Katarina K. ; Hortobagyi, Gabriel N. ; Komorowski, Anna A. ; Chouinard, Edmond E. ; Young, Robyn R. ; Gnant, Michael ; Pritchard, Kathleen ; Bennett, Lee L. ; Ricci, Jean Francois J.F. ; Bauly, Hounayda H. ; Taran, Tetiana T. ; Sahmoud, Tarek ; Noguchi, Shinzaburo S.
Informations sur la publication : Cancer, 119, 10, (page 1908-1915)
Statut de publication : Publié, 2013-05
Sujet CREF : Cancérologie
Mots-clés : advanced breast cancer
everolimus
exemestane
health-related quality of life
hormone receptor-positive
Mots-clés MeSH : Adult
Aged
Androstadienes -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Aromatase Inhibitors -- administration & dosage
Breast Neoplasms -- drug therapy -- pathology -- psychology
Disease Progression
Double-Blind Method
Drug Administration Schedule
Female
Health Status
Humans
Middle Aged
Odds Ratio
Postmenopause
Proportional Hazards Models
Quality of Life
Questionnaires
Sirolimus -- administration & dosage -- analogs & derivatives
Treatment Outcome
Note : SCOPUS: ar.j
FLWIN
Langue :
  • Anglais
Identificateurs : urn:issn:0008-543X 
info:doi/10.1002/cncr.28010
info:pmid/23504821